Granules India share news, announcements and annual reports
NSE: GRANULESBSE: 532482Pharmaceuticals & BiotechnologySmall Cap
Granules India Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2002 on BSE, Jun 2005 on NSE
Last close ₹837.35down ₹3.10 (0.37%)BSE ₹836.60
Share price at the NSE close on 29 Oct 2026. Previous close ₹840.45.
29 Oct: open ₹840.00, high ₹842.85, low ₹820.00
52-week range of traded prices to 29 Oct 2026
₹529.85Low, 25 Nov 2025₹923.65High, 15 Sep 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22,841 Cr403rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.49
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.21%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,08,57563.3% delivered
Granules India orders, deals and press releases
208 filed, newest first. Page 4 of 5.
Aug 2014
Jul 2014
Jun 2014
May 2014
Apr 2014
Jan 2014
Dec 2013
31 Dec · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated December 31, 2013 has allotted 24,000 equity shares in consequent to exercise of options under ESOP 2009.
Oct 2013
17 Oct · Business
Share Transfer and shareholders/Investors Grievance Committee at their meeting dated October 16, 2013 have approved to allot 5,000 equity shares in consequent to excercise of options under ESOP 2009.
Sep 2013
2 Sep · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated August 31, 2013 have approved to allot 13000 equity shares in consequent to exercise of options under ESOP 2009.
Aug 2013
13 Aug · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated August 13, 2013 have approved to allot 9,000 equity shares in consequent to exercise of options under ESOP 2009.2 Aug · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated August 02, 2013 have approved to allot 11,000 equity shares in consequent to exercise of options under ESOP 2009.
Jul 2013
11 Jul · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated July 11, 2013 have approved to allot 72,000 equity shares in consequent to exercise of options under ESOP 2002 & ESOP 2009.
Jun 2013
12 Jun · Business
Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated June 12, 2013 has approved to allot 16,000 equity shares in consequent to exercise of options under ESOP 2009.
Apr 2013
25 Apr · Business
Share Transfer and Shareholders/ Investors Grievance Committee at their meeting dated April 25, 2013 has approved to allot 5,000 equity shares in consequent to exercise of options under ESOP 2009.
Jan 2013
24 Jan · Business
Share Transfer and Shareholders/ Investors Grievance Committee at their meeting dated January 23, 2013 has approved to allot 5,000 equity shares in consequent to exercise of options under ESOP 2002.
Oct 2012
26 Oct · Business
Share Transfer and Shareholders/ Investors Grievance Committee at their meeting dated October 25, 2012 has approved to allot 50,000 equity shares in consequent to exercise of options under ESOP 2002.
Sep 2012
Jul 2012
Apr 2012
Jan 2012
Oct 2011
Jul 2011
Jan 2011
Oct 2010
Jul 2010
Apr 2010
29 Apr · Business
Press release dated April 29, 2010 , titled "Granuels India Receives U.S. FDA Approval for its Metformin ANDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
22 Jan · Business
Press release dated January 22, 2010, titled "Granules India posts Record Revenue for a Quarter: Net Revenue of Rs. 122.40 Cr. posted for Q3 FY'10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
26 Oct · Business
Press release dated October 26, 2009, titled "Granules Posts Record Revenue, Net Profit Increases 121%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Oct · Business
Press release dated October 09, 2009, titled "Granules donates Rs.10 lakhs to CM Relief Fund". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
25 Sep · Business
Press release dated September 25, 2009, titled "Granules bags the coveted 'Fastest Emerging Company from India' Award". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
11 Aug · Business
Vide its letter dated August 11, 2009, regarding a press release dated August 10, 2009, titled "Granules India signs up agreement for manufacturing and supply of material finished dosage". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
27 Jul · Business
Granules India Limited had informed the Exchange regarding a press release dated July 25, 2009, titled "Granules India posts high profits in Q1 FY'10; Net profit up by 229%". The Company has now informed the Exchange regarding a revised press release dated July 27, 2009, titled "Granules India posts high profits in Q1 FY'10; Net profit up by 129%". A copy of the revised press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Jul · Business
Press release dated July 25, 2009, titled "Granules India posts high profits in Q1 FY'10 : Net profit up by 229%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
Jan 2008
24 Jan · Business
Press release dated January 24, 2008, titled "Granules India Q2 FY08 Net Sales up 5.44 per cent at Rs 53 Crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
27 Oct · Business
Press release dated October 27, 2007, titled "Granules India Q1FY08 Net Sales up 10 per cent at Rs 50 cr". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
30 Jul · Business
Press release dated July 30, 2007, titled "Granules India FY07 Net Profit up 14.61 per cent at Rs.10.59 crs". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Jul · Business
Press release dated July 05, 2007, titled "Heritage and Granules Enter into Strategic Alliance for the Development, Supply and Marketing of Generic Products for the U.S. Market". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
14 May · Business
Press release on receipt of approvals from US FDA for the facilities of the Company. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.